Seattle’s life sciences vacancy rate surged 540 basis points year over year to 19 percent in the second quarter as new lab space...
ByThe RegistryJuly 9, 2026A onetime evangelical sanctuary on Monte Villa Parkway has been gutted and rebuilt into one of the few dedicated cryobiology research labs in...
ByThe RegistryJune 25, 2026A new BSI executive brief argues that the greater Seattle region’s overlapping environmental, workforce and climate regulations have raised the operational bar for...
ByThe RegistryJune 24, 2026The U.S. life sciences real estate market has finally bottomed out after four years of turbulence, according to JLL’s new national lab report,...
ByThe RegistryJune 12, 2026Eli Lilly’s $1.5 billion cash deal for Bothell-based Curevo Vaccine is the kind of validating, capital-attracting exit Puget Sound’s life sciences cluster has...
ByThe RegistryMay 28, 2026Lake Union flagship anchors Alexandria’s bet on the region’s institutional research base while peripheral inventory languishes. Seattle’s life science real estate market is...
ByThe RegistryApril 28, 2026The world’s largest alternative asset manager is betting its real estate franchise on AI infrastructure while waiting for logistics and multifamily to rebound...
ByThe RegistryApril 24, 2026The sale of 1401 Madison St. reflects a broader repositioning by major hospital systems as medical outpatient real estate commands record pricing nationwide....
ByThe RegistryApril 20, 2026Savills says supply surge from pandemic-era development boom is outpacing demand, leaving major lab projects unleased across key hubs A development cycle that...
ByThe RegistryApril 16, 2026The half-acre parcel in Seattle carries a master use permit for an 11-story, 305,000-square-foot life-science and office project designed by Perkins+Will for Trammell...
ByThe RegistryApril 9, 2026A pandemic-era construction wave has collided with cooling demand, leaving nearly 60 million square feet of new lab space struggling to find tenants...
ByThe RegistryApril 9, 2026Two major projects enter Greater Seattle’s lab market in 2025 with moderate preleasing as NIH and venture capital funding both decline year over...
ByThe RegistryMarch 17, 2026